These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28399844)

  • 21. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD.
    Navaneethan SD; Jolly SE; Schold JD; Arrigain S; Nakhoul G; Konig V; Hyland J; Burrucker YK; Dann PD; Tucky BH; Sharp J; Nally JV
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1418-1427. PubMed ID: 28778854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States.
    Murphy DP; Drawz PE; Foley RN
    J Am Soc Nephrol; 2019 Jul; 30(7):1314-1321. PubMed ID: 31167823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m-Power Heart Project - a nurse care coordinator led, mHealth enabled intervention to improve the management of hypertension in India: study protocol for a cluster randomized trial.
    Srinivasapura Venkateshmurthy N; Ajay VS; Mohan S; Jindal D; Anand S; Kondal D; Tandon N; Rao MB; Prabhakaran D
    Trials; 2018 Aug; 19(1):429. PubMed ID: 30086778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease.
    Chu CD; Xia F; Du Y; Singh R; Tuot DS; Lamprea-Montealegre JA; Gualtieri R; Liao N; Kong SX; Williamson T; Shlipak MG; Estrella MM
    JAMA Netw Open; 2023 Jul; 6(7):e2326230. PubMed ID: 37498594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial.
    Heisler M; Hofer TP; Schmittdiel JA; Selby JV; Klamerus ML; Bosworth HB; Bermann M; Kerr EA
    Circulation; 2012 Jun; 125(23):2863-72. PubMed ID: 22570370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Kidney Awareness Registry and Education (KARE) study: protocol of a randomized controlled trial to enhance provider and patient engagement with chronic kidney disease.
    Tuot DS; Velasquez A; McCulloch CE; Banerjee T; Zhu Y; Hsu CY; Handley M; Schillinger D; Powe NR
    BMC Nephrol; 2015 Oct; 16():166. PubMed ID: 26494562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics.
    Bansal S; Mader M; Pugh JA
    Kidney360; 2020 Sep; 1(9):904-915. PubMed ID: 35369564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of chronic kidney disease and its risk factors among family practice patients in Lithuania.
    Bumblyte IA; Zilinskiene A; Vanholder R; Valius L; Kuzminskis V
    Clin Nephrol; 2012 Sep; 78(3):198-206. PubMed ID: 22874108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Foti KE; Wang D; Chang AR; Selvin E; Sarnak MJ; Chang TI; Muntner P; Coresh J
    Kidney Int; 2021 Mar; 99(3):686-695. PubMed ID: 33637204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving proteinuria screening with mailed smartphone urinalysis testing in previously unscreened patients with hypertension: a randomized controlled trial.
    Leddy J; Green JA; Yule C; Molecavage J; Coresh J; Chang AR
    BMC Nephrol; 2019 Apr; 20(1):132. PubMed ID: 30999886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease in type 2 diabetes: Does an abnormal urine albumin-to-creatinine ratio need to be retested?
    Garg D; Naugler C; Bhella V; Yeasmin F
    Can Fam Physician; 2018 Oct; 64(10):e446-e452. PubMed ID: 30315036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.
    Clark LA; Whitmire S; Patton S; Clark C; Blanchette CM; Howden R
    J Med Econ; 2017 Jul; 20(7):715-722. PubMed ID: 28332417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study.
    van Mil D; Kieneker LM; Evers-Roeten B; Thelen MHM; de Vries H; Hemmelder MH; Dorgelo A; van Etten RW; Heerspink HJL; Gansevoort RT
    Lancet; 2023 Sep; 402(10407):1052-1064. PubMed ID: 37597522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.
    Vassalotti JA; Centor R; Turner BJ; Greer RC; Choi M; Sequist TD;
    Am J Med; 2016 Feb; 129(2):153-162.e7. PubMed ID: 26391748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicomponent intervention to improve blood pressure management in chronic kidney disease: a protocol for a pragmatic clinical trial.
    Kilgallon JL; Gannon M; Burns Z; McMahon G; Dykes P; Linder J; Bates DW; Waikar S; Lipsitz S; Baer HJ; Samal L
    BMJ Open; 2021 Dec; 11(12):e054065. PubMed ID: 34937722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physician and patient tools to improve chronic kidney disease care.
    Sequist TD; Holliday AM; Orav EJ; Bates DW; Denker BM
    Am J Manag Care; 2018 Apr; 24(4):e107-e114. PubMed ID: 29668213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient discourse on chronic kidney disease monitoring: a qualitative study at a Veterans Affairs Renal Clinic.
    Vandenberg AE; Echt KV; Johnson TM; Bowling CB
    BMC Nephrol; 2018 Jul; 19(1):183. PubMed ID: 30025520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled R
    Al Hamarneh YN; Tsuyuki RT; Jones CA; Manns B; Tonelli M; Scott-Douglass N; Jindal K; Tink W; Hemmelgarn BR
    Am J Kidney Dis; 2018 Jan; 71(1):42-51. PubMed ID: 28912054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.